Sign in

CIK 0000725363

  • Non-accelerated filer
  • Smaller reporting company

CEL SCI CORP

Sign in to watch
Ticker
CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
CO
Entity type
Operating
EIN
840916344
Phone
+1 703-506-9460
Business address
8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
  1. 4 Grant or award Senior Vice President acquired 309 shares (grant or award)
  2. 4 Grant or award Chief Scientific Officer acquired 205 shares (grant or award)
  3. 4 Grant or award Senior Vice President acquired 335 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 366 shares (grant or award)
  5. 4 Open-market buy Director bought 100 shares at $14.24 ($1,424)
  6. 4 Open-market buy Director bought 800 shares at $11.68 ($9,343)
  7. 4 Open-market buy Director bought 800 shares at $11.77 ($9,416)
  8. 4 Open-market buy Director bought 800 shares at $11.77 ($9,416)
  9. 4 Open-market sale Senior Vice President sold 10,000 shares at $12.73 ($127,290)
  10. 4 Open-market buy Director bought 3,000 shares at an average $11.35 ($34,060)
  11. 4 Grant or award Senior Vice President acquired 275 shares (grant or award)
  12. 4 Grant or award Chief Scientific Officer acquired 188 shares (grant or award)
  13. 4 Grant or award Senior Vice President acquired 297 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 335 shares (grant or award)
  15. 4 Grant or award Senior VP, Research acquired 228 shares (grant or award)
  16. 4 Grant or award Chief Scientific Officer acquired 160 shares (grant or award)
  17. 4 Grant or award Senior VP, Operations acquired 245 shares (grant or award)
  18. 4 Grant or award CEO acquired 286 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 41 · 806 filings